Imrecoxib — impurities and related standards

All 3 Imrecoxib-related compounds in the CATO catalogue, listed with their CAS numbers, molecular formulae and stock status. If the compound you need is not listed, send the structure or the impurity designation and we will check whether it can be synthesised or isolated.

Imrecoxib is a selective cyclooxygenase-2 inhibitor that has been studied as an anti-inflammatory and analgesic agent for conditions such as osteoarthritis. Its related-substance work concentrates on the synthetic route and on the selectivity question: process impurities and intermediates carried through the synthesis, degradation products formed during storage, and structurally similar analogues whose residual cyclooxygenase-2 activity may need to be characterised. The imrecoxib standards listed on this page are non-compendial impurities supplied as individual characterised lots, intended to support process-impurity profiling, impurity identification in stability studies, and the development of chromatographic methods for this molecule.

Request a quote or email [email protected]